Cargando…
The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621698/ https://www.ncbi.nlm.nih.gov/pubmed/36327999 http://dx.doi.org/10.1016/S1473-3099(22)00693-4 |
_version_ | 1784821603209576448 |
---|---|
author | Arora, Prerna Zhang, Lu Nehlmeier, Inga Kempf, Amy Cossmann, Anne Dopfer-Jablonka, Alexandra Schulz, Sebastian R Jäck, Hans-Martin Behrens, Georg M N Pöhlmann, Stefan Hoffmann, Markus |
author_facet | Arora, Prerna Zhang, Lu Nehlmeier, Inga Kempf, Amy Cossmann, Anne Dopfer-Jablonka, Alexandra Schulz, Sebastian R Jäck, Hans-Martin Behrens, Georg M N Pöhlmann, Stefan Hoffmann, Markus |
author_sort | Arora, Prerna |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9621698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96216982022-11-01 The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages Arora, Prerna Zhang, Lu Nehlmeier, Inga Kempf, Amy Cossmann, Anne Dopfer-Jablonka, Alexandra Schulz, Sebastian R Jäck, Hans-Martin Behrens, Georg M N Pöhlmann, Stefan Hoffmann, Markus Lancet Infect Dis Correspondence Elsevier Ltd. 2022-12 2022-10-31 /pmc/articles/PMC9621698/ /pubmed/36327999 http://dx.doi.org/10.1016/S1473-3099(22)00693-4 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Arora, Prerna Zhang, Lu Nehlmeier, Inga Kempf, Amy Cossmann, Anne Dopfer-Jablonka, Alexandra Schulz, Sebastian R Jäck, Hans-Martin Behrens, Georg M N Pöhlmann, Stefan Hoffmann, Markus The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages |
title | The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages |
title_full | The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages |
title_fullStr | The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages |
title_full_unstemmed | The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages |
title_short | The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages |
title_sort | effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging sars-cov-2 ba.4 and ba.5 sublineages |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621698/ https://www.ncbi.nlm.nih.gov/pubmed/36327999 http://dx.doi.org/10.1016/S1473-3099(22)00693-4 |
work_keys_str_mv | AT aroraprerna theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT zhanglu theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT nehlmeieringa theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT kempfamy theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT cossmannanne theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT dopferjablonkaalexandra theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT schulzsebastianr theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT jackhansmartin theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT behrensgeorgmn theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT pohlmannstefan theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT hoffmannmarkus theeffectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT aroraprerna effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT zhanglu effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT nehlmeieringa effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT kempfamy effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT cossmannanne effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT dopferjablonkaalexandra effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT schulzsebastianr effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT jackhansmartin effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT behrensgeorgmn effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT pohlmannstefan effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages AT hoffmannmarkus effectofcilgavimabandneutralisationbyvaccineinducedantibodiesinemergingsarscov2ba4andba5sublineages |